Alica J Emhardt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Alica J Emhardt

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

ACS Synthetic Biology|December 20, 2014

Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulationMichael Agne, Ilona Blank, Alica J Emhardt, et al.

Science Translational Medicine|February 23, 2018

Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasmsAlessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.

Pageof 1

Search research articles

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

ACS Synthetic Biology|December 20, 2014

Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulationMichael Agne, Ilona Blank, Alica J Emhardt, et al.

Science Translational Medicine|February 23, 2018

Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasmsAlessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.

Pageof 1